Tuesday, May 22, 2018
Tags Merck

Tag: Merck

Germany’s Merck Seeks Partners for Cancer and Immune System Drugs

By Ludwig Burger and Patricia Weiss FRANKFURT (Reuters)  Merck KGaA will seek development partners for experimental treatments including tepotinib as the German company looks to licensing...

Merck’s Keytruda Helps Lung Cancer Patients Live Longer in Trial

By Tamara Mathias (Reuters) Merck & Co's blockbuster drug Keytruda helped previously untreated lung cancer patients live longer in a late-stage trial, potentially cementing its...

Roche’s Tecentriq Cocktail Adds to Lung Cancer Survival Success

ZURICH (Reuters) Roche's Tecentriq immunotherapy combined with other drugs boosted lung cancer patients' survival versus an older cocktail, the Swiss company said as it seeks...

Roche’s Tecentriq Notches Third Cancer Cocktail Trial Win

By John Miller ZURICH (Reuters) Roche's immunotherapy Tecentriq on Tuesday racked up a third trial win in combination with other cancer drugs, a boost for...

Eisai Clinches Merck Deal to Develop and Sell Cancer Drug, Shares...

By Bill Berkrot and Sam Nussey NEW YORK/TOKYO (Reuters) Merck & Co Inc and Japan's Eisai Co Ltd have signed a potential multibillion-dollar collaboration to...

Roche Notches Fresh Win amid Crowd of Immunotherapy Cocktails

By John Miller ZURICH (Reuters) Roche's Tecentriq mixed with an older drug cut the risk of death in kidney cancer, marking another win for the Swiss...
banner